Cardiac fatty acid metabolism and the induction of apoptosis

American Journal of the Medical Sciences

Volumn 318, Issue 1, 1999, Pages 15-21

  Sparagna, Genevieve C ^a   Hickson Bick, Diane L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Fatty acids; Heart; Mitochondria

Indexed keywords

CASPASE; CYTOCHROME C OXIDASE; FATTY ACID; PALMITIC ACID; PROTEIN BCL 2; STEARIC ACID;

APOPTOSIS; CONFERENCE PAPER; ENZYME ACTIVATION; FATTY ACID METABOLISM; HEART DISEASE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HUMAN; NONHUMAN; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 0033513464     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40567-1     Document Type: Conference Paper

References (98)

1. Bing RJ. Cardiac metabolism. Physiol Rev 1964;45:171-213.
2. Lopaschuk GD, Spafford M, Marsh DR. Glycolysis is predominant source of myocardial ATP production immediately after birth. Am J Physiol 1991;261:H1698-705.
3. Lopaschuk GD, Spafford MA. Energy substrate utilization by isolated working hearts of newborn rabbits. Am J Physiol 1990;258:H1274-80.
4. Lopaschuk GD, Gamble J. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart. Can J Physiol Pharmacol 1993;72:1101-9.
5. Mueller HS, Ayres ST. Metabolic responses of the heart in acute myocardial infarction in man. Am J Cardiol 1978;42: 363-71.
6. Oliver MR, Kurien VA, Greenwood TW. Relation between serum-free-fatty acid and arrhythmia and death after myocardial infarction. Lancet 1968;1:710-5.
7. Svensson S, Svedjeholm R, Ekroth R, et al. Trauma metabolism and the heart: uptake of substrates and effects of insulin early after cardiac operations. J Thorac Cardiovasc Surg 1990;99:1063-73.
8. Fraze E, Donner CC, Swislocki ALM, et al. Ambient plasma free fatty acid concentration in noninsulin-dependent diabetes mellitus. J Clin Endocrinol 1985;61:807-11.
9. Egan BM, Hennes MMI, Stepniakowski KT, et al. Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension 1996;27:723-8.
10. Laws A. Free fatty acids, insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 1996;7:172-7.
11. Lewis GF, Uffelman KD, Szeto LW, et al. Interaction between free fatty acid and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995;95:158-66.
12. Wall SR, Lopaschuk GD. Glucose oxidation rates in fatty acid perfused isolated working hearts from diabetic rats. Biochim Biophys Acta 1989;1006:97-103.
13. Kagaya Y, Kanno Y, Takeyame D. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. Circulation 1990;81:1353-61.
14. Strauss AW, Powell CK, Hale DE. Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase and sudden death in childhood. Proc Natl Acad Sci U S A 1995;92:10496-500.
15. Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75: 426-33.
16. Lopaschuk GD. Alterations in fatty acid oxidation during reperfusion of the heart after myocardial ischemia. Am J Cardiol 1997;80:11A-6A.
17. Lopaschuk GD, Spafford MA, Davies NJ, Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 1990;66:546-53.
18. Liedtke AJ, Nellis SH, Mjos OD. Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic hearts. Am J Physiol 1984;247:H387-94.
19. Idell-Wanger JA, Grotjohann LW, Neely JR. Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 1978;253:4310-8.
20. Corr PB, Gross RW, Sobel BE. Amphiphatic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 1984;55:135-54.
21. Kotaka K, Miyazaki Y, Ogawa K, et al. Reversal of ischemia-induced mitochondrial dysfunction after coronary reperfusion. J Mol Cell Cardiol 1982;14:223-31.
22. Katz AM, Messineo FC. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 1981;48:1-16.
23. Hockenbery D. Defining apoptosis. Am J Pathol 1995;146: 16-9.
24. Wyllie AH. Apoptosis: an overview. Br Med Bull 1997;53: 451-65.
25. Majno G, Joris I. Apoptosis, oncosis, and necrosis: An overview of cell death. Am J Pathol 1995;146:3-15.
26. Harrison DJ, Wyllie AH. Apoptosis: An overview of the process and its relevance in disease. Adv Pharmocol 1997;41: 1-35.
27. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-41.
28. Bromme HJ, Holtz J. Apoptosis in the heart: when and why? Mol Cellular Biochem 1996;163-164:261-75.
29. Tomei LD. Apoptosis in the heart. Adv Pharmacol 1997;41: 383-407.
30. Gottlieb RA, Burleson KO, Kloner RA, et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-8.
31. Itoh G, Tamura J, Suzuki M, et al. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 1995;146:1325-31.
32. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
33. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996;79:949-56.
34. Teiger E, Dam T-V, Richard L, et al. Apotopsis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 1996;97:2891-7.
35. Leri A, Liu Y, Malhotra A, et al. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circ 1998;97:194-203.
36. Krown KA, Page MT, Nguyen C, et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996;98:2854-65.
37. Buttke TM. Inhibition of lymphocyte proliferation by free fatty acids. I. Differential effects on mouse B and T lymphocytes. Immunology 1984;53:235-42.
38. Zhang CL, Lyngmo V, Nordoy A. The effects of saturated fatty acids on endothelial cells. Thromb Res 1992;65:65-75.
39. DeVries JE, Roemen TH, VanderVusse GJ, et al. Saturated but not mono-unsaturated fatty acids induce death in neonatal rat ventricular cardiomyocytes [abstract]. Eur J Physiol 1995;S430:R67.
40. DeVries JE, York M, Roemen THM, et al. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 1997;38: 1384-94.
41. Pena LA, Fuks Z, Kolesnick R. Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 1997; 53:615-21.
42. Obeid LM, Hannun YA. Ceramide: a novel lipid mediator of apoptosis. Adv Pharmacol 1997;41:133-54.
43. Ariga T, Jarvis WD, Yu RK. Role of sphingolipid-mediated cell death in neurodegenrative diseases. J Lipid Res 1998;39: 1-16.
44. Hannun Y. Functions of ceramide in coordinating cellular responses to stress. Science 1996;274:1855-9.
45. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993;259: 1769-71.
46. Jarvis WD, Kolesnick RN, Fornari FA, et al. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci U S A 1994;91: 73-7.
47. Kim M, Y, Linardic C, Obeid L, et al. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem 1991;266: 484-9.
48. Dressier KA, Mathins S, Kolesnick RN. Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science 1992;255:1715-8.
49. Haimovitz-Friedman A, Kan C-C, Ehleiter D, et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994;180:525-35.
50. Bielawska AE, Shapiro JP, Jiang L, et al. Ceramide is involved in triggering of cardiomyocyte apotosis induced by ischemia and reperfusion. Am J Pathol 1997;151:1257-63.
51. Hannun YA, Obeid LM. Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci 1995;20:73-7.
52. Kolesnick R, Fuks Z. Ceramide: a signal for apoptosis or mitogenesis? J Exp Med 1995;181:1949-52.
53. Paumen MB, Ishida Y, Muramatsu M, et al. Inhibition of carnitine palmitoyltransferae I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem 1997; 272:3324-9.
54. Riboni L, Viani P, Bassi R, et al. The role of sphingolipids in the process of signal transduction. Prog Lipid Res 1997;36: 153-95.
55. Kanada K, Hara T, Nishijima M, et al. A mammalian homolog of the yeast LCB1 encodes a component of serine palmitoyltransferase, the enzyme catalyzing the first step in sphingolipid synthesis. J Biol Chem 1997;272:32108-14.
56. McGarry JD, Leatherman GF, Foster DW. Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J Biol Chem 1978;253:4128-36.
57. Awan MM, Saggerson ED. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J 1993;295:61-6.
58. Kudo N, Barr AJ, Barr RL, et al. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 1995;270:17513-20.
59. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
60. Wang ZQ. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 1995;9:509-20.
61. Lemaire C, Andreau K, Souvannavong V, et al. Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Letts 1998;425:266-70.
62. Haimovitz-Friedman A, Kolesnick RN, et al. Ceramide signalling in apoptosis. British Med Bulletin 1997;53:539-53.
63. Pronk JG, Ramer K, Amiri P. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 1995;271:808-10.
64. Yoshimura S, Banno Y, Nakashima S, et al. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. J Biol Chem 1998;273:6921-7.
65. Yaoita H, Ogawa K, Maehara K, et al. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 1998;97:276-81.
66. Kyriakis JM, Avruch J. Sounding, the alarm: Protein kinase cascades activated by stress and inflammation. J Biol Chem 1996;271:24313-6.
67. Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994;369:156-60.
68. Pombo CM, Bonventre JV, Avruch J, et al. The stress-activated protein kinases are major c-Jun amino-termmal kinases activated by ischemia and reperfusion. J Biol Chem 1994;269:26546-54.
69. Bogoyevitch MA, Ketterman AJ, Sugden PH. Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 1995;270: 29710-7.
70. Raingeaud J, Gupta S, Rogers JS, et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995;270:7420-6.
71. Knight RJ, Buxton DB. Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. Biochem Biophys Res Commun 1996;218:83-8.
72. Wang Y, Huang S, Sah VP, et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 1998;273:2161-8.
73. Verheij M, Bose R, Lin XH, et al. Requirement of ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996;380:75-9.
74. Pennica D, King KL, Shaw KJ, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A 1995;92:1142-6.
75. Sheng Z, Knowlton K, Chen J, et al. Cardiotropin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase dependent pathway. J Biol Chem 1997; 272:5783-91.
76. Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995;182:367-77.
77. Marchetti P, Castedo M, Susin SA, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996;184:1155-60.
78. Bernardi P. The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta 1996;1275:5-9.
79. Quillet-Mary A, Jaffrezou J-P, Mansat V, et al. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 1997;272:21388-95.
80. Petit PX, Zamzami N, Vayssiere J-L, et al. Implication of mitochondria in apoptosis. Mol Cell Biochem 1997;174: 185-8.
81. Decaudin D, Geley S, Hirsch T, et al. Bcl-2 and Bcl-xL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 1997;57:62-7.
82. Garcia-Ruiz C, Colell A, Mari M, et al. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. J Biol Chem 1997; 272:11369-77.
83. Liu X, Kim CN, Yang J, et al. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell 1996;86:147-57.
84. Newmeyer DD, Farshon DM, Reed JC. Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 1994; 79:353-64.
85. Reed JC. Cytochrome c: can't live with it - can't live without it. Cell 1997;91:559-62.
86. Brown R. The bcl-2 family of proteins. Br Med Bull 1996;53: 466-77.
87. Vaux D, Cory S, Adams J. Bcl-2 gene promotes haematopoeitic cell survival and co-operates with c-myc to immortalize pre-B cells. Nature 1988;335:440-2.
88. Kluck RM, Bossy-Weltzel E, Green DR, et al. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6.
89. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275:1129-32.
90. Adachi S, Cross AR, Babior BM, et al. Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J Biol Chem 1997;272: 21878-82.
91. Zhivotovsky B, Orrenius S, Brustugun OT, et al. Injected cytochrome c induces apoptosis. Nature 1998;391:449-50.
92. Li F, Srinivasan A, Wang Y, et al. Cell-specific induction of apoptosis by microinjection of cytochrome c. J Biol Chem 1997;272:30299-305.
93. Rosse T, Oliver R, Monney L, et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 1998;391:496-9.
94. Murphy AN, Bredesen DE, Cortopassi G, et al. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci U S A 1996;93:9893-8.
95. L regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997;91:627-37.
96. Cai J, Jones DP. Superoxide in apoptosis: Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 1998; 273:11401-4.
97. Lesnefsky EJ, Tandler B, Ye J, et al. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol 1997; 273:H1544-54.
98. Paumen MB, Ishida Y, Han H, et al. Direct interaction of the mitochondrial membrane protein carnitine palmitoyl-transferase I with bcl-2. Biochem Biophys Res Commun 1997; 231:523-5.